HomeHOSPITALSNorthwell Health to Advance Health Care Innovation Amid COVID-19 Pandemic at Constellation Forum

Northwell Health to Advance Health Care Innovation Amid COVID-19 Pandemic at Constellation Forum

Northwell Health will host its third annual Constellation Forum virtually on Thursday, August 6 from 11 a.m. to 2 p.m. This year’s Forum will focus on the coronavirus disease 2019 (COVID-19) pandemic as it has highlighted the increased demands on health care innovation and on those who bring it to life. All are welcome to register for the free event here.

The Constellation Forum will explore what can be learned from efforts today in order to prepare whatever comes next. Northwell’s President and CEO, Michael Dowling, and an influential group of leaders, including Eric Schmidt, Former CEO & Chairman of Google and Co-Founder of Schmidt Futures; Joaquin Duato, Vice Chairman of the Executive Committee from Johnson & Johnson; Kevin Lobo, Chief Executive Officer of Stryker; Ann Lamont, Co-Founder & Managing Partner at Oak HC/FT; Cori Bargmann, Head of Science at the Chan Zuckerberg Initiative; Stanley Bergman, Chairman of the Board & CEO of Henry Schein; Geoffrey Ling, Founding Director of DARPA Biological Technologies Office and Chief Executive Officer of On Demand Pharmaceuticals and, Kevin Tracey, President and CEO of the Feinstein Institutes for Medical Research will come together to share insights, best practices and the challenges facing health care amid this unprecedented time in order to collectively advance health care innovation.

To recognize Governor Andrew Cuomo for his leadership during this crisis, he will be presented with an honorary degree and provide remarks.

“Northwell Health has been at the center of the COVID-19 pandemic, treating more patients than any other health system globally and is working vigorously to overcome its challenges,” said Mr. Dowling. “This Forum gives us the chance to further enhance collaboration and accelerate changes within health care to benefit not only our patients but also patients around the world.”

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

Stay Connected

spot_img

Don't Miss

Hinge Health Acquires the Most Advanced Computer Vision Technology for Tracking Human Motion

CEO Daniel Perez explained, “We won’t stop investing in technology to deliver the most patient-centered digital clinic that improves member experience and outcomes while reducing costs. wrnch allows us to take a giant leap forward in all respects.”

Dale W Wood Congratulates the Huma Team on Raising $130 Million

Major health and technology companies across the world have committed upwards of $130 million to Huma Therapeutics, the health-tech company backed by Dale Ventures.

Rhaeos Awarded $4 Million NIH SBIR Grant

Under the NIH SBIR grant, Rhaeos will leverage their existing wireless sensor hardware to provide additional quantitative flow data to the clinician, giving insight into this currently inaccessible and highly relevant shunt performance metric.

Gynesonics Announces FDA Clearance of Next Generation Sonata System

“This clearance brings significant system improvements that expand the location of fibroids that can be treated while allowing the physician to control all aspects of the treatment from within the sterile field,” said Jiayu Chen, Ph.D. Vice President, Engineering and Advanced Technologies at Gynesonics.

Blackrock Neurotech Invests In Groundbreaking Auditory Nerve Implant With University Of Minnesota And MED-EL

The new investment will enable the development and translation of a new ANI through preclinical studies and later, a pilot clinical trial, where the ANI is then implanted in up to three deaf patients.

Jonathan Chapman: New President/CEO of Trividia Health

Chapman said, “I’m honored to join the Trividia team as President and CEO. This organization has a long history of leadership within the healthcare industry as a provider of accurate, accessible, and affordable point-of-care solutions for the management of diabetes.”

SOLOPASS® System (Bedside Neuro-Navigation Device) Receives FDA 510(k) Clearance

inTRAvent’s SOLOPASS® system brings simple, portable, bedside neuro-navigation into the intensive care unit.

Skyhawk Therapeutics Completes New Investment Round

A $133 million round of investment will allow Skyhawk to accelerate development of its novel small molecule RNA-modifying drug candidates into the clinic.

By using this website you agree to accept Medical Device News Magazine Privacy Policy